SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001819790-21-000027
Filing Date
2021-08-05
Accepted
2021-08-04 17:40:28
Documents
57
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tars-20210630.htm   iXBRL 10-Q 1107949
2 EX-31.1 exhibit31111.htm EX-31.1 11875
3 EX-31.2 exhibit31211.htm EX-31.2 12131
4 EX-32.1 exhibit32111.htm EX-32.1 9962
5 EX-32.2 exhibit32211.htm EX-32.2 9904
  Complete submission text file 0001819790-21-000027.txt   5094218

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tars-20210630.xsd EX-101.SCH 31438
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tars-20210630_cal.xml EX-101.CAL 63111
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tars-20210630_def.xml EX-101.DEF 134309
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tars-20210630_lab.xml EX-101.LAB 426941
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tars-20210630_pre.xml EX-101.PRE 271591
11 EXTRACTED XBRL INSTANCE DOCUMENT tars-20210630_htm.xml XML 824017
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39614 | Film No.: 211145350
SIC: 2836 Biological Products, (No Diagnostic Substances)